Non-peptide ligands for peptide receptors

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Peptide analogs offer improved stability for studying peptide-receptor systems.
• Peptide ligands often lack oral bioavailability and long duration, limiting therapeutic use.
• Development of non-peptidal ligands is a key research focus.

Purpose of the Study:

• To review progress in developing non-peptidal ligands for various receptor systems.
• To compare lead compounds in opioid, CCK-gastrin, and angiotensin II fields.
• To discuss strategies and successes in non-peptidal ligand discovery.

Main Methods:

• Literature review and comparison of lead compounds.
• Analysis of screening results from natural and synthetic sources.
• Discussion of rational design approaches based on peptide leads.

Main Results:

• Significant progress in identifying non-peptidal ligands for opioid, CCK-gastrin, and angiotensin II receptors.
• Screening of natural and synthetic compound collections has been highly successful.
• Rational design has proven more challenging, with notable exceptions like ACE inhibitors.

Conclusions:

• Non-peptidal ligands represent a promising avenue for developing orally active, long-duration therapeutics.
• Diverse strategies, particularly screening, are effective for discovering these ligands.
• Continued research is essential for advancing non-peptidal drug development across various receptor targets.